Abstract: The invention concerns a nutritional or therapeutic agent comprising a molecule mix obtained from Vitis vinifera and Vaccinium angustifolium, comprising: at least 1% of catechins and epicatechins, the percentage being given by weight in relation to the total weight of the mix, preferably at least 5%, at least 5 ppm (parts per million in the mix) of ferulic acid, preferably at least 10 ppm. The invention also relates to the use of this agent due to its effects on cognitive functions in particular.

Abstract: The invention concerns a plant extract obtained from saffron, with a safranal concentration, measured using the HPLC method, of a minimum of 0.2% in weight relative to the total dry matter weight. The invention also concerns a procedure for obtaining such an extract, as well as compositions including this extract, and its use.

Abstract: A plant extract obtained from saffron, with a safranal concentration, measured using the HPLC method, of a minimum of 0.2% by weight relative to the total dry matter weight. A method for obtaining the plant extract, as well as compositions comprising the plant extract, and methods of treatment.

Abstract: The invention concerns a nutritional or therapeutic agent comprising a molecule mix obtained from Vitis vinifera and Vaccinium angustifolium, comprising: at least 1% of catechins and epicatechins, the percentage being given by weight in relation to the total weight of the mix, preferably at least 5%, at least 5 ppm (parts per million in the mix) of ferulic acid, preferably at least 10 ppm. The invention also relates to the use of this agent due to its effects on cognitive functions in particular.

Abstract: A vehicle container has a vehicle container body, a door pivotally connected to the vehicle container body, the door defining at least one recess, and a door latch system for locking the door in a closed position. The door latch system has an extendible and retractable actuator pivotally connected to the vehicle container body, a linkage assembly operatively connected to the actuator, a rod operatively connected to the linkage assembly, the rod being pivotable about an axis upon extension and retraction of the actuator, at least one hook connected to the rod, the at least one hook being received and withdrawn from the at least one recess of the door by pivoting the rod about the axis, and at least one pin removably fastened to the door and extending in the at least one recess, the at least one pin being selectively movable relative to the door.

Abstract: A system for assembling a door to a vehicle container having first and second pillars includes a first base adapted for connection to a top portion of the first pillar, a second base adapted for connection to a top portion of the second pillar, and a hinge assembly adapted for pivotally connecting the door to the vehicle container. The hinge assembly is adapted to be removably connected to the first and second bases and to the door. The hinge assembly is selected from first and second hinge assemblies. When the first hinge assembly pivotally connects the door to the vehicle container, the door has a first pivoting configuration. When the second hinge assembly pivotally connects the door to the vehicle container, the door has a second pivoting configuration being different from the first pivoting configuration. A vehicle container and a door for a vehicle container are also encompassed.

Abstract: The invention concerns a nutritional or therapeutic agent comprising a molecule mix obtained from Vitis vinifera and Vaccinium angustifolium, comprising: at least 1% of catechins and epicatechins, the percentage being given by weight in relation to the total weight of the mix, preferably at least 5%, at least 5 ppm (parts per million in the mix) of ferulic acid, preferably at least 10 ppm. The invention also relates to the use of this agent due to its effects on cognitive functions in particular.

Abstract: In an embodiment, a system includes a processor coupled with a data store, the at least one processor configured to: receive a client product version number from a client device; identify a differential bundle based on a difference between the client product version number and a current product version number, wherein the differential bundle comprises a set of bytewise differences between an executable client product binary file associated with the client product version number and a executable current product binary file associated with the current product version number; determine whether the differential bundle is available in the data store; retrieve the differential bundle from the data store in response to determining that the differential bundle is available in the data store; produce the differential bundle in response to determining that the differential bundle is not available in the data store; and send the differential bundle to the client device.

Abstract: In an embodiment, a system includes a processor coupled with a data store, the at least one processor configured to: receive a client product version number from a client device; identify a differential bundle based on a difference between the client product version number and a current product version number, wherein the differential bundle comprises a set of bytewise differences between an executable client product binary file associated with the client product version number and a executable current product binary file associated with the current product version number; determine whether the differential bundle is available in the data store; retrieve the differential bundle from the data store in response to determining that the differential bundle is available in the data store; produce the differential bundle in response to determining that the differential bundle is not available in the data store; and send the differential bundle to the client device.

Abstract: An approach is proposed to support version control for integrating updated web-based components with a native application of a mobile device. A new version of a mini app is received at an application version control module configured to control versioning of the mini app and the native application, wherein the mini app includes one or more web-based features in JavaScript to be integrated with the native application. Version compatibility checks are performed to confirm that the new version of the mini app only contains native dependencies that match with a version of the native application the version of the mini app depends on. The new version of the mini app is integrated with the native application into the target mobile application if the version compatibility checks pass. Finally, the target mobile application is uploaded to an app store to make the target mobile application available to an end user.

Abstract: An approach is proposed to support version control for integrating updated web-based components with a native application of a mobile device. A new version of a mini app is received at an application version control module configured to control versioning of the mini app and the native application, wherein the mini app includes one or more web-based features in JavaScript to be integrated with the native application. Version compatibility checks are performed to confirm that the new version of the mini app only contains native dependencies that match with a version of the native application the version of the mini app depends on. The new version of the mini app is integrated with the native application into the target mobile application if the version compatibility checks pass. Finally, the target mobile application is uploaded to an app store to make the target mobile application available to an end user.

Abstract: A plant extract obtained from saffron, with a safranal concentration, measured using the HPLC method, of a minimum of 0.2% by weight relative to the total dry matter weight. A method for obtaining the plant extract, as well as compositions comprising the plant extract, and methods of treatment.

Abstract: An approach is proposed to support cross-platform information exchange mechanism for integration of web-based components with a native application. First, mini apps are imported to a platform of a mobile device, wherein the mini apps are web-based features assembled and packaged together in JavaScript to be deployed to and integrated with the application native to the platform. A bridge enables bi-directional communication between the mini apps in JavaScript and the native to the platform by marshalling native code of the native application into a JavaScript project to be integrated with the imported mini apps and un-marshalling the mini apps in JavaScript to the native code of the native application. The mini apps are then integrated with the native application on the mobile device over the bridge to create a target mobile application, which is uploaded to an app store to make the target mobile application available to an end user.

Abstract: An approach is proposed to support automatic API generation for integration of web-based components with a native application. First, mini apps are included in a container, wherein the mini apps are web-based features assembled together as a bundle of JavaScript assets to be integrated with the native application on a mobile device. A set of APIs to the mini apps are then automatically generated based on pre-defined schemas in native code specific to the platform of the mobile device and merged with the mini apps into the container. The container is published to a repository at a central, team shared, location and imported to the mobile device for integration with the native application. Finally, a target mobile application is created by integrating the mini apps with the native application on the mobile device via the APIs, wherein the target mobile application is uploaded and made available to an end user.

Abstract: The invention concerns a nutritional or therapeutic agent comprising a molecule mix obtained from Vitis vinifera and Vaccinium angustifolium, comprising: at least 1% of catechins and epicatechins, the percentage being given by weight in relation to the total weight of the mix, preferably at least 5%, at least 5 ppm (parts per million in the mix) of ferulic acid, preferably at least 10 ppm. The invention also relates to the use of this agent due to its effects on cognitive functions in particular.

Abstract: A dump body for a truck has rear left and right pillars, a tailgate pivotally connected to the pillars, left and right upper rails connected to the rear left and right pillars at their rear ends, a front wall connected to the front ends of the upper rails, a left side wall connected to the front wall, the left upper rail and the rear left pillar, a right side wall connected to the front wall, the right upper rail and the rear right pillar, a floor connected to the front wall, the rear pillars, and the lower ends of the side walls, and front and rear support assemblies connected to an underside of front and rear portions of the floor. A majority of an underside portion of the floor located longitudinally between the support assemblies is free of structural support members. A truck having the dump body is also described.

Abstract: The present invention relates to the use of a composition comprising a superoxide dismutase (SOD) enzyme and/or an active plant extract containing SOD, for stimulating the overexpression of plant antioxidant enzymatic proteins, stimulating plant vitality and/or increasing plant productivity and/or preventively or curatively protecting said plants against biotic or abiotic stresses.

Abstract: The present invention relates to the use of a composition comprising a superoxide dismutase (SOD) enzyme and/or an active plant extract containing SOD, for stimulating the overexpression of plant antioxidant enzymatic proteins, stimulating plant vitality and/or increasing plant productivity and/or preventively or curatively protecting said plants against biotic or abiotic stresses.

Abstract: A method of enhancing physical performance during exercise by administering an amount of a grape extract effective to treat a subject. A preferred grape extract comprises a concentration of flavanol monomers of greater than about 5% by weight, and more preferably within a range from about 12% by weight to about 50% by weight, and a concentration of flavanol dimers preferably greater than about 2% by weight, and more preferably within a range from about 6% by weight to about 20% by weight. The flavanol monomers preferably include catechin, epicatechin, epicatechin gallate, and gallic acid. The flavanol dimers preferably include procyanidin B1, procyanidin B2, procyanidin B3, procyanidin B4, and procyanidin B2-O-gallate.

Abstract: A method of controlling body weight in humans by administering an amount of decaffeinated green coffee extract effective to treat a subject. A preferred green coffee extract contains a ratio of 5-caffeoylquinic acid (5-CQA) and total chlorogenic acids (tCGA) (5-CQA/tCGA) of between about 0.2 and 0.3. More preferably, the concentration of tCGA is greater than about 45% and the concentration of 5-CQA is less than about 10%. A preferred method of administration consists of administering between about 200 mg and about 1,000 mg per day, more preferably administering about 400 mg per day.